ReviewMicrobial biotechnology2010
Advances in Campylobacter biology and implications for biotechnological applications.
Review in Microbial biotechnology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 38 citations in OpenAlex.
- Temporal dynamics of gene expression during the development ofMicrobial genomics · 2025Article
- The Global Challenge ofTropical medicine and infectious disease · 2025Review
- Campylobacter jejuni virulence factors: update on emerging issues and trends.Journal of biomedical science · 2024Review
- Article
- Live-Attenuated Oral Vaccines to ReduceVaccines · 2022Article
- TheMicroorganisms · 2021Article
- Bacteriophage-Mediated Modulation of Bacterial Competition during Selective Enrichment of Campylobacter.Microbiology spectrum · 2021Article
- Virulence Traits of InpatientMicroorganisms · 2020Article
- Uncovering complex microbiome activities via metatranscriptomics during 24 hours of oral biofilm assembly and maturation.Microbiome · 2018Article
- Insights into the impact of flhF inactivation on Campylobacter jejuni colonization of chick and mice gut.BMC microbiology · 2018Article
- Association between the ambient temperature and the occurrence of human Salmonella and Campylobacter infections.Scientific reports · 2016Article
- Adhesion, Biofilm Formation, and Genomic Features of Campylobacter jejuni Bf, an Atypical Strain Able to Grow under Aerobic Conditions.Frontiers in microbiology · 2016Article
- Cell Wall Anchoring of the Campylobacter Antigens to Lactococcus lactis.Frontiers in microbiology · 2016Article
- Regulation of oxidative stress resistance in Campylobacter jejuni, a microaerophilic foodborne pathogen.Frontiers in microbiology · 2015Review
- A negative effect of Campylobacter capsule on bacterial interaction with an analogue of a host cell receptor.BMC microbiology · 2014Article
- Target optimization for peptide nucleic acid (PNA)-mediated antisense inhibition of the CmeABC multidrug efflux pump in Campylobacter jejuni.The Journal of antimicrobial chemotherapy · 2014Article
- Molecular mechanisms and biological role of Campylobacter jejuni attachment to host cells.European journal of microbiology & immunology · 2012Review
- New molecular tools for enhancing methane production, explaining thermodynamically limited lifestyles and other important biotechnological issues.Microbial biotechnology · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Campylobacter jejuni is a major foodborne pathogen of animal origin and a leading cause of bacterial gastroenteritis in humans. During the past decade, especially since the publication of the first C. jejuni genome sequence, major advances have been made in understanding the pathobiology and physiology of this organism. It is apparent that C. jejuni utilizes sophisticated mechanisms for effective colonization of the intestinal tracts in various animal species. Although Campylobacter is fragile in the environment and requires fastidious growth conditions, it exhibits great flexibility in the adaptation to various habitats including the gastrointestinal tract. This high adaptability is attributable to its genetically, metabolically and phenotypically diverse population structure and its ability to change in response to various challenges. Unlike other enteric pathogens, such as Escherichia coli and Salmonella, Campylobacter is unable to utilize exogenous glucose and mainly depends on the catabolism of amino acids as a carbon source. Campylobacter proves highly mutable in response to antibiotic treatments and possesses eukaryote-like dual protein glycosylation systems, which modify flagella and other surface proteins with specific sugar structures. In this review we will summarize the distinct biological traits of Campylobacter and discuss the potential biotechnological approaches that can be developed to control this enteric pathogen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.